[시장보고서]기질 혈관 분획(SVF) 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2034년)

기질 혈관 분획(SVF) 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2034년)

Stromal Vascular Fraction Market (Product: Instruments, Kits and Reagents, and Others; and Method: Aspiration, Transfer, and Isolation (Enzymatic and Non-enzymatic)) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

상품코드 : 1508839

리서치사 : Transparency Market Research

발행일 : 2024년 05월

페이지 정보 : 영문 190 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,795

￦ 8,182,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,795

￦ 12,418,000

PDF (Multi-user License)

PDF 보고서를 동일 부서 5명이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste가 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 11,795

￦ 16,654,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 기질 혈관 분획(SVF) 시장에 대해, 2024-2034년의 예측 기간에 시장의 지표에 관한 귀중한 인사이트를 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회에 대해서도 조사하고 있습니다. 2024년을 기준년, 2034년을 예측년으로 2018-2034년 세계의 기질 혈관 분획 시장의 매출과 예측을 제공하고 있습니다. 또한 2024-2034년 세계의 기질 혈관 분획 시장의 연평균 성장률(CAGR %)도 제공합니다.

본 리포트는 광범위한 조사를 거쳐 작성되고 있습니다. 1차 조사에서는 애널리스트가 주요 오피니언 리더, 산업 리더, 오피니언 제조업체에 대한 인터뷰를 시행했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연간 리포트, 프레스 릴리스, 관련 자료 등을 참조하여 기질 혈관 분획 시장을 이해했습니다.

시장 스냅숏
2023년 시장 규모	1억 5,290만 달러
2034년 시장 규모	2억 8,010만 달러
CAGR	5.2%

세계의 기질 혈관 분획 시장의 경쟁 구도에 대해 조사하고 있습니다. 세계의 기질 혈관 분획 시장에서 사업을 운영하는 주요 기업이 식별되고, 각 기업이 다양한 속성 측면에서 프로파일링되고 있습니다. 기업 개요, 재무 상황, 최근 동향, SWOT 등이 본 리포트에서 소개되고 있는 세계의 기질 혈관 분획 시장에서 기업의 속성입니다.

시장 기업 - 경쟁 매트릭스(기업 계층과 규모별)
시장 점유율 분석, 기업별(2022년)
기업 개요
- Plus Therapeutics Inc.
- GE Healthcare(Biosafe Gp SA)(Cytiva)
- Tissue Genesis Inc.
- Human Med AG Inc.
- InGeneron, Inc.
- Allergen PLC(Abbvie)
- GID Group, Inc.
- Bimini Health Tech
- Laboratorios Fidia Farmaceutica S.L.U.

KSA

영문 목차

영문목차

Stromal Vascular Fraction Market - Scope of Report

TMR's report on the global stromal vascular fraction market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global stromal vascular fraction market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global stromal vascular fraction market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the stromal vascular fraction market.

Market Snapshot
Market Value in 2023	US$ 152.9 Mn
Market Value in 2034	US$ 280.1 Mn
CAGR	5.2%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global stromal vascular fraction market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global stromal vascular fraction market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global stromal vascular fraction market.

The report delves into the competitive landscape of the global stromal vascular fraction market. Key players operating in the global stromal vascular fraction market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global stromal vascular fraction market profiled in this report.

Key Questions Answered in Global stromal vascular fraction Market Report:

What is the sales/revenue generated by stromal vascular fraction across all regions during the forecast period?
What are the opportunities in the global stromal vascular fraction market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Stromal Vascular Fraction Market - Research Objectives and Research Approach

The comprehensive report on the global stromal vascular fraction market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global stromal vascular fraction market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global stromal vascular fraction market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Stromal Vascular Fraction Market

4. Market Overview

4.1. Introduction
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Stromal Vascular Fraction Market Analysis and Forecasts, 2020-2034
4.5. Porter's Five Force Analysis

5. Key Insights

5.1. Value Chain Analysis
5.2. Porters Five Forces of Analysis
5.3. Key Industry Events
5.4. Regulatory Scenario by Global/Regional

6. Global Stromal Vascular Fraction Market Analysis and Forecasts, By Product

6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product, 2020-2034
- 6.3.1. Instruments
- 6.3.2. Kits and Reagents
- 6.3.3. Others
6.4. Market Attractiveness By Product

7. Global Stromal Vascular Fraction Market Analysis and Forecasts, By Method

7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Method, 2020-2034
- 7.3.1. Aspiation
- 7.3.2. Transfer
- 7.3.3. Isolation
  - 7.3.3.1. Enzymatic
  - 7.3.3.2. Non-Enzymatic
7.4. Market Attractiveness By Method

8. Global Stromal Vascular Fraction Market Analysis and Forecasts, By Application

8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Application, 2020-2034
- 8.3.1. Cosmetic Application
- 8.3.2. Orthopedic Application
- 8.3.3. Soft Tissue Application
- 8.3.4. Others
8.4. Market Attractiveness By Application

9. Global Stromal Vascular Fraction Market Analysis and Forecasts, By End-user

9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By End-user, 2020-2034
- 9.3.1. Hospitals
- 9.3.2. Specialty Clinics
- 9.3.3. Others
9.4. Market Attractiveness By End-user

10. Global Stromal Vascular Fraction Market Analysis and Forecasts, By Region

10.1. Key Findings
10.2. Market Value Forecast By Region
- 10.2.1. North America
- 10.2.2. Europe
- 10.2.3. Asia Pacific
- 10.2.4. Latin America
- 10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region

11. North America Stromal Vascular Fraction Market Analysis and Forecast

11.1. Introduction
- 11.1.1. Key Findings
11.2. Market Value Forecast By Product , 2020-2034
- 11.2.1. Instruments
- 11.2.2. Kits and Reagents
- 11.2.3. Others
11.3. Market Value Forecast By Method, 2020-2034
- 11.3.1. Aspiration
- 11.3.2. Transfer
- 11.3.3. Isolation
  - 11.3.3.1. Enzymatic
  - 11.3.3.2. Non-Enzymatic
11.4. Market Value Forecast By Application, 2020-2034
- 11.4.1. Cosmetic Application
- 11.4.2. Orthopedic Application
- 11.4.3. Soft Tissue Application
- 11.4.4. Others
11.5. Market Value Forecast By End-user, 2020-2034
- 11.5.1. Hospitals
- 11.5.2. Specialty Clinics
- 11.5.3. Others
11.6. Market Value Forecast By Country, 2020-2034
- 11.6.1. U.S.
- 11.6.2. Canada
11.7. Market Attractiveness Analysis
- 11.7.1. By Product
- 11.7.2. By Method
- 11.7.3. By Application
- 11.7.4. By End-user
- 11.7.5. By Country

12. Europe Stromal Vascular Fraction Market Analysis and Forecast

12.1. Introduction
- 12.1.1. Key Findings
12.2. Market Value Forecast By Product , 2020-2034
- 12.2.1. Instruments
- 12.2.2. Kits and Reagents
- 12.2.3. Others
12.3. Market Value Forecast By Method, 2020-2034
- 12.3.1. Aspiration
- 12.3.2. Transfer
- 12.3.3. Isolation
  - 12.3.3.1. Enzymatic
  - 12.3.3.2. Non-Enzymatic
12.4. Market Value Forecast By Application, 2020-2034
- 12.4.1. Cosmetic Application
- 12.4.2. Orthopedic Application
- 12.4.3. Soft Tissue Application
- 12.4.4. Others
12.5. Market Value Forecast By End-user, 2020-2034
- 12.5.1. Hospitals
- 12.5.2. Specialty Clinics
- 12.5.3. Others
12.6. Market Value Forecast By Country, 2020-2034
- 12.6.1. Germany
- 12.6.2. U.K.
- 12.6.3. France
- 12.6.4. Spain
- 12.6.5. Italy
- 12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
- 12.7.1. By Product
- 12.7.2. By Method
- 12.7.3. By Application
- 12.7.4. By End-user
- 12.7.5. By Country

13. Asia Pacific Stromal Vascular Fraction Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value Forecast By Product , 2020-2034
- 13.2.1. Instruments
- 13.2.2. Kits and Reagents
- 13.2.3. Others
13.3. Market Value Forecast By Method, 2020-2034
- 13.3.1. Aspiration
- 13.3.2. Transfer
- 13.3.3. Isolation
  - 13.3.3.1. Enzymatic
  - 13.3.3.2. Non-Enzymatic
13.4. Market Value Forecast By Application, 2020-2034
- 13.4.1. Cosmetic Application
- 13.4.2. Orthopedic Application
- 13.4.3. Soft Tissue Application
- 13.4.4. Others
13.5. Market Value Forecast By End-user, 2020-2034
- 13.5.1. Hospitals
- 13.5.2. Specialty Clinics
- 13.5.3. Others
13.6. Market Value Forecast By Country, 2020-2034
- 13.6.1. China
- 13.6.2. Japan
- 13.6.3. India
- 13.6.4. Australia & New Zealand
- 13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
- 13.7.1. By Product
- 13.7.2. By Method
- 13.7.3. By Application
- 13.7.4. By End-user
- 13.7.5. By Country

14. Latin America Stromal Vascular Fraction Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Market Value Forecast By Product , 2020-2034
- 14.2.1. Instruments
- 14.2.2. Kits and Reagents
- 14.2.3. Others
14.3. Market Value Forecast By Method, 2020-2034
- 14.3.1. Aspiration
- 14.3.2. Transfer
- 14.3.3. Isolation
  - 14.3.3.1. Enzymatic
  - 14.3.3.2. Non-Enzymatic
14.4. Market Value Forecast By Application, 2020-2034
- 14.4.1. Cosmetic Application
- 14.4.2. Orthopedic Application
- 14.4.3. Soft Tissue Application
- 14.4.4. Others
14.5. Market Value Forecast By End-user, 2020-2034
- 14.5.1. Hospitals
- 14.5.2. Specialty Clinics
- 14.5.3. Others
14.6. Market Value Forecast By Country, 2020-2034
- 14.6.1. Brazil
- 14.6.2. Mexico
- 14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
- 14.7.1. By Product
- 14.7.2. By Method
- 14.7.3. By Application
- 14.7.4. By End-user
- 14.7.5. By Country

15. Middle East & Africa Stromal Vascular Fraction Market Analysis and Forecast

15.1. Introduction
- 15.1.1. Key Findings
15.2. Market Value Forecast By Product , 2020-2034
- 15.2.1. Instruments
- 15.2.2. Kits and Reagents
- 15.2.3. Others
15.3. Market Value Forecast By Method, 2020-2034
- 15.3.1. Aspiration
- 15.3.2. Transfer
- 15.3.3. Isolation
  - 15.3.3.1. Enzymatic
  - 15.3.3.2. Non-Enzymatic
15.4. Market Value Forecast By Application, 2020-2034
- 15.4.1. Cosmetic Application
- 15.4.2. Orthopedic Application
- 15.4.3. Soft Tissue Application
- 15.4.4. Others
15.5. Market Value Forecast By End-user, 2020-2034
- 15.5.1. Hospitals
- 15.5.2. Specialty Clinics
- 15.5.3. Others
15.6. Market Value Forecast By Country, 2020-2034
- 15.6.1. GCC Countries
- 15.6.2. South Africa
- 15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
- 15.7.1. By Product
- 15.7.2. By Method
- 15.7.3. By Application
- 15.7.4. By End-user
- 15.7.5. By Country

16. Competition Landscape

16.1. Market Player - Competition Matrix (By Tier and Size of companies)
16.2. Market Share Analysis By Company (2022)
16.3. Company Profiles
- 16.3.1. Plus Therapeutics Inc.
  - 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.1.2. Product Portfolio
  - 16.3.1.3. Financial Overview
  - 16.3.1.4. SWOT Analysis
  - 16.3.1.5. Strategic Overview
- 16.3.2. GE Healthcare (Biosafe Gp SA) (Cytiva)
  - 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.2.2. Product Portfolio
  - 16.3.2.3. Financial Overview
  - 16.3.2.4. SWOT Analysis
  - 16.3.2.5. Strategic Overview
- 16.3.3. Tissue Genesis Inc.
  - 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.3.2. Product Portfolio
  - 16.3.3.3. Financial Overview
  - 16.3.3.4. SWOT Analysis
  - 16.3.3.5. Strategic Overview
- 16.3.4. Human Med AG Inc.
  - 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.4.2. Product Portfolio
  - 16.3.4.3. Financial Overview
  - 16.3.4.4. SWOT Analysis
  - 16.3.4.5. Strategic Overview
- 16.3.5. InGeneron, Inc.
  - 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.5.2. Product Portfolio
  - 16.3.5.3. Financial Overview
  - 16.3.5.4. SWOT Analysis
  - 16.3.5.5. Strategic Overview
- 16.3.6. Allergen PLC (Abbvie)
  - 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.6.2. Product Portfolio
  - 16.3.6.3. Financial Overview
  - 16.3.6.4. SWOT Analysis
  - 16.3.6.5. Strategic Overview
- 16.3.7. GID Group, Inc.
  - 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.7.2. Product Portfolio
  - 16.3.7.3. Financial Overview
  - 16.3.7.4. SWOT Analysis
  - 16.3.7.5. Strategic Overview
- 16.3.8. Bimini Health Tech
  - 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.8.2. Product Portfolio
  - 16.3.8.3. Financial Overview
  - 16.3.8.4. SWOT Analysis
  - 16.3.8.5. Strategic Overview
- 16.3.9. Laboratorios Fidia Farmaceutica S.L.U.
  - 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.9.2. Product Portfolio
  - 16.3.9.3. Financial Overview
  - 16.3.9.4. SWOT Analysis
  - 16.3.9.5. Strategic Overview

한글목차

목차

제1장 서문

제2장 전제조건과 조사 방법

제3장 주요 요약 : 세계 시장

제4장 시장 개요

제5장 주요 인사이트

제6장 세계 시장 분석과 예측 : 제품별

제7장 세계 시장 분석과 예측 : 방법별

제8장 세계 시장 분석과 예측 : 용도별

제9장 세계 시장 분석과 예측 : 최종사용자별

제10장 세계 시장 분석과 예측 : 지역별

제11장 북미의 시장 분석과 예측

제12장 유럽의 시장 분석과 예측

제13장 아시아태평양의 시장 분석과 예측

제14장 라틴아메리카의 시장 분석과 예측

제15장 중동 및 아프리카의 시장 분석과 예측

제16장 경쟁 구도